Speaker illustration

Professor Gabriele Giacomo Schiattarella

Charite University Hospital, Berlin (Germany)

Gabriele Schiattarella is a cardiologist-scientist whose research focuses on molecular mechanisms of remodeling in the disease-stressed myocardium. He received his MD in 2009 from the University Federico II of Naples (Italy). After completing a fellowship in Cardiology at the same university (2015) and matriculating in a PhD program in Experimental Medicine, he moved to University of Texas Southwestern Medical Center in Dallas, Texas, USA where he completed his PhD program and currently serve as researcher. Gabriele’s background is in medicine, experimental cardiology and cellular/molecular biology, with specific training and expertise in murine models of cardiovascular disease and preclinical assessment of cardiovascular function. His research interests include molecular mechanisms of cardiac hypertrophy and heart failure (HFpEF and HFrEF); mitochondrial dysfunction, reactive oxygen species production and nitrosative stress in cardiomyocytes as well as regulation of protein quality

Therapeutic advances in cardiometabolic HFpEF: pharmacotherapy and lifestyle intervention

Event: ESC Congress 2025

Topic: Cardiovascular Pharmacotherapy

Session type: Symposium

Thumbnail

Metabolic, immune, and cellular drivers of HFpEF pathogenesis and progression

Event: ESC Congress 2025

Topic: Heart Failure

Session type: Moderated ePosters

Thumbnail

The floor is yours: bring your questions on management of cardiovascular-kidney-metabolic syndrome

Event: ESC Congress 2025

Topic: Cardiovascular Pharmacotherapy

Session type: Bring your Questions

Thumbnail

What's new for GLP-1 agonist and SGLT2 inhibitor cardiovascular pharmacotherapy?

Event: ESC Congress 2025

Topic: Antidiabetic Pharmacotherapy

Session type: Abstract Sessions

Thumbnail

Mechanisms of cardiomyopathy and heart failure: from fibroblast dynamics to metabolic remodelling

Event: ESC Congress 2025

Topic: Heart Failure

Session type: Moderated ePosters

Thumbnail

The cardiometabolic syndrome and extracardiac drug effects beneficial to the heart

Event: HFA Winter Research Meeting on Translational Heart Failure 2025

Topic: Drugs, Drug Targets

Session type: Symposium

Thumbnail

Chronic heart failure - epidemiology, prognosis, outcome 7

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Thumbnail

Valvular heart disease

Event: Heart Failure 2023

Topic: Valvular Heart Disease

Session type: Moderated ePosters

Thumbnail

Multi-omics for personalised medicine

Event: HFA Winter Research Meeting on Translational Heart Failure 2023

Topic: Cardiomyopathies

Session type: Symposium

Thumbnail

Pathomechanisms of heart failure with preserved ejection fraction

Event: ESC Congress 2022

Topic: Heart Failure

Session type: Moderated ePosters

Thumbnail